NCT04880512View on ClinicalTrials.gov

The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

August 20, 2022

Study Completion Date

December 20, 2022

Conditions
Healthy Subjects
Interventions
DRUG

SYHX 1901 tablets

SYHX 1901, oral tablets, in fasted state

DRUG

Placebo

Matching placebo, oral tablets, in fasted state

Trial Locations (1)

Unknown

RECRUITING

Huashan Hospital of Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY